Lupus erythematosus panniculitis: Clinicopathological, immunophenotypic, and molecular studies

American Journal of Dermatopathology

Volumn 32, Issue 1, 2010, Pages 24-30

  Park, Hyun Sun ^a   Choi, Jung Won ^a   Kim, Byoung Kwon ^b   Cho, Kwang Hyun ^a  

^a Seoul National University   (South Korea)

^b Armed Forces Capital Hospital   (South Korea)

Author keywords

Lupus erythematosus panniculitis; Lupus profundus

Indexed keywords

ANTIMALARIAL AGENT; CYCLOPHOSPHAMIDE; DAPSONE; DOXORUBICIN; ETOPOSIDE; HYDROXYCHLOROQUINE; IFOSFAMIDE; METHOTREXATE; PREDNISOLONE; STEROID; VINCRISTINE;

ADULT; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; FAT NECROSIS; FEMALE; GENE REARRANGEMENT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPH FOLLICLE; MALE; PANNICULITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKIN LYMPHOMA; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; B-LYMPHOCYTES; BIOLOGICAL MARKERS; CHILD; DAPSONE; DRUG THERAPY, COMBINATION; FAT NECROSIS; FEMALE; GENE REARRANGEMENT, GAMMA-CHAIN T-CELL ANTIGEN RECEPTOR; HUMANS; HYDROXYCHLOROQUINE; IMMUNOENZYME TECHNIQUES; IMMUNOPHENOTYPING; MALE; METHOTREXATE; MIDDLE AGED; PANNICULITIS, LUPUS ERYTHEMATOSUS; PREDNISOLONE; RETROSPECTIVE STUDIES; SKIN; T-LYMPHOCYTES; YOUNG ADULT;

EID: 77649099988     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/DAD.0b013e3181b4a5ec     Document Type: Article

References (31)

1. Caproni M, Palleschi GM, Papi C, et al. Discoid lupus erythematosus lesions developed on lupus erythematosus profundus nodules. Int J Dermatol. 1995;34:357-359.
2. Requena L, Sanchez Yus E. Panniculitis. Part II. Mostly lobular panniculitis. J Am Acad Dermatol. 2001;45:325-361; quiz 362-1324
3. Diaz-Jouanen E, DeHoratius RJ, Alarcon-Segovia D, et al. Systemic lupus erythematosus presenting as panniculitis (lupus profundus). Ann Intern Med. 1975;82:376-379.
4. Tuffanelli DL. Lupus erythematosus panniculitis (profundus). Arch Dermatol. 1971;103:231-242.
5. Peters MS, Su WP. Lupus erythematosus panniculitis. Med Clin North Am. 1989;73:1113-1126.
6. Jacyk WK, Bhana KN. Lupus erythematosus profundus in black South Africans. Int J Dermatol. 2006;45:717-721.
7. Magro CM, Crowson AN, Kovatich AJ, et al. Lupus profundus, indeterminate lymphocytic lobular panniculitis and subcutaneous T-cell lymphoma: a spectrum of subcuticular T-cell lymphoid dyscrasia. J Cutan Pathol. 2001;28:235-247.
8. Martens PB, Moder KG, Ahmed I. Lupus panniculitis: clinical perspectives from a case series. J Rheumatol. 1999;26:68-72.
9. Massone C, Kodama K, Salmhofer W, et al. Lupus erythematosus panniculitis (lupus profundus): clinical, histopathological, and molecular analysis of nine cases. J Cutan Pathol. 2005;32:396-404.
10. Ng PP, Tan SH, Tan T. Lupus erythematosus panniculitis: a clinicopathologic study. Int J Dermatol. 2002;41:488-490.
11. Watanabe T, Tsuchida T. Lupus erythematosus profundus: a cutaneous marker for a distinct clinical subset? Br J Dermatol. 1996;134:123-125.
12. Cho KH, Lee DY, Kim CW. Erythema induratum of Bazin. Int J Dermatol. 1996;35:802-808.
13. Signoretti S, Murphy M, Cangi MG, et al. Detection of clonal T-cell receptor gamma gene rearrangements in paraffin-embedded tissue by polymerase chain reaction and nonradioactive single-strand conformational polymorphism analysis. Am J Pathol. 1999;154:67-75.
14. Theriault C, Galoin S, Valmary S, et al. PCR analysis of immunoglobulin heavy chain (IgH) and TCR-gamma chain gene rearrangements in the diagnosis of lymphoproliferative disorders: results of a study of 525 cases. Mod Pathol. 2000;13:1269-1279.
15. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25: 1271-1277.
16. Winkelmann RK. Panniculitis in connective tissue disease. Arch Dermatol. 1983;119:336-344.
17. Sanchez NP, Peters MS, Winkelmann RK. The histopathology of lupus erythematosus panniculitis. J Am Acad Dermatol. 1981;5:673-680.
18. Moscona R, Bergman R, Friedman-Birnbaum R. Multiple dermal grafts for hemifacial atrophy caused by lupus panniculitis. J Am Acad Dermatol. 1986;14:840-843.
19. Fountain RB. Lupus erythematosus profundus. Br J Dermatol. 1968;80: 571-579.
20. de Argila D, la Moneda C, Iglesias L. Epidermal changes are not unusual in lupus erythematosus profundus. Int J Dermatol. 1996;35:680.
21. Pichardo RO, Lu D, Sangueza OP, et al. What is your diagnosis? Lupus profundus. Am J Dermatopathol. 2002;24:507-508.
22. Fleischmajer R, Nedwich A. Generalized morphea. I. Histology of the dermis and subcutaneous tissue. Arch Dermatol. 1972;106:509-514.
23. Harris RB, Duncan SC, Ecker RI, et al. Lymphoid follicles in subcutaneous inflammatory disease. Arch Dermatol. 1979;115:442-443.
24. Massone C, Chott A, Metze D, et al. Subcutaneous, blastic natural killer (NK), NK/T-cell, and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients. Am J Surg Pathol. 2004;28:719-735.
25. Aguilera P, Mascaro JM Jr, Martinez A, et al. Cutaneous gamma/delta T-cell lymphoma: a histopathologic mimicker of lupus erythematosus profundus (lupus panniculitis). J Am Acad Dermatol. 2007;56:643-647.
26. Gonzalez CL, Medeiros LJ, Braziel RM, et al. T-cell lymphoma involving subcutaneous tissue. A clinicopathologic entity commonly associated with hemophagocytic syndrome. Am J Surg Pathol. 1991;15:17-27.
27. Cassis TB, Fearneyhough PK, Callen JP. Subcutaneous panniculitis-like T-cell lymphoma with vacuolar interface dermatitis resembling lupus erythematosus panniculitis. J Am Acad Dermatol. 2004;50:465-469.
28. Hoque SR, Child FJ, Whittaker SJ, et al. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathological, immunophenotypic and molecular analysis of six patients. Br J Dermatol. 2003;148:516-525.
29. Magro CM, Crowson AN, Byrd JC, et al. Atypical lymphocytic lobular panniculitis. J Cutan Pathol. 2004;31:300-306.
30. Ackerman AB. Decline of a discipline: abetment by journals. J Cutan Pathol. 2005;32:254, author reply 254.
31. Smedby KE, Baecklund E, Askling J. Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics. Epidemiol Biomarkers Prev. 2006;15:2069-2077.